Conclusion
High rates of drug-drug interactions and inappropriate prescribing were
reported among ESRD patients who were on QTcP-inducing drugs in
outpatient clinics in Jordan. These findings urge policymakers to
implement educational programme for patients and continual training
courses for pharmacists and physicians to ensure safe delivery of
medications to the ESRD patients.